Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Dauntless who wrote (3380)	4/16/1998 3:57:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Dauntless, You actually don't know. You're guessing on the basis of other experiences. Someone I like on the Apple thread posted that he knew what the earnings would be. He was sure and he's a nice guy, but he was very far off. You're sure and you're a nice guy, but you really don't KNOW. Wasn't the filing for the FDA supposed to have occurred before? I assume that SGP is doing it in order to get the most clout possible, to try to maximize their investment, but if the drug isn't worthy of approval, then it still won't be approved. LIPO's stock price was based on everyone being sure that it would be a billion dollar drug. A lot of rich and famous people bought it, as well as some poor and not famous people, and no one was running around saying that the drug wasn't approvable. Suddenly the company announced that the drug failed Phase III, showed no better than placebo, and the stock went from 26, where I'd bought it, to 8 or so, and then more slowly, down to 5. The company was honest in announcing the story, and they didn't try to fudge anything. I lost a ton of money in that stock. Linda